scispace - formally typeset
H

Henning Stehr

Researcher at Stanford University

Publications -  73
Citations -  5350

Henning Stehr is an academic researcher from Stanford University. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 21, co-authored 62 publications receiving 3561 citations.

Papers
More filters
Journal ArticleDOI

Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors.

TL;DR: The authors showed that mutations affecting the CREBBP lysine acetyltransferase (KAT) domain are common lesions in FL cancer precursor cells, with potential for discriminating subjects at risk of developing FL or monitoring residual disease.
Journal ArticleDOI

Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes

TL;DR: The proposed model can identify high-risk patients, who may benefit from more intensive brain MRI surveillance to reduce morbidity of subsequent treatment through early detection of brain metastasis.
Journal ArticleDOI

Hierarchy in Somatic Mutations Detected in Circulating and Tissue-Resident Follicular Lymphoma Precursors before Clinical Diagnosis

TL;DR: This work analyzed prediagnostic blood and non-malignant lymph node samples to identify other early changes associated with eventual FL, correlated with biopsies of subsequent tumors where available, and found concordance suggestive of a precursor clonal population in 8 of 10 FL patients.
Journal ArticleDOI

Genomic landscape of T-large granular lymphocyte leukemia and chronic lymphoproliferative disorder of NK cells: a single institution experience.

TL;DR: This article investigated the genomic profiles of LGLL with a focus on STAT3 and STAT5B mutations in a cohort of 49 patients (41 T-LGLL, 8 CLPD-NK) and found that the average number of pathogenic/likely pathogenic mutations in STAT3/STAT5B-mutated patients was significantly higher than that in WT patients.